itopride
Trade name: Ganaton
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
3
Earliest trial started Nov 18, 2021 (NCT04918017)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- AcetylcholinesteraseANTAGONIST
ACE antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07254715 | Phase 4 | Dec 31, 2025 | Ain Shams University |
| NCT07031479 | Phase 4 | Jul 1, 2025 | Chulalongkorn University |
| NCT04918017 | Phase 4 | Nov 18, 2021 | University of Malaya |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Chulalongkorn University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Malaya | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1